Literature DB >> 22085902

Determination of the real effect of genes identified in GWAS: the example of IL2RA in multiple sclerosis.

Marie-Claude Babron1, Hervé Perdry, Adam E Handel, Sreeram V Ramagopalan, Vincent Damotte, Bertrand Fontaine, Bertram Müller-Myhsok, George C Ebers, Françoise Clerget-Darpoux.   

Abstract

Genome-wide association studies (GWAS), although efficient to detect genes involved in complex diseases, are not designed to measure the real effect of the genes. This is illustrated here by the example of IL2RA in multiple sclerosis (MS). Association between IL2RA and MS is clearly established, although the functional variation is still unknown: the effect of IL2RA might be better described by several SNPs than by a single one. This study investigates whether a pair of SNPs better explains the observed linkage and association data than a single SNP. In total, 522 trio families and 244 affected sib-pairs were typed for 26 IL2RA SNPs. For each SNP and pairs of SNPs, the phased genotypes of patients and controls were compared to determine the SNP set offering the best risk discrimination. Consistency between the genotype risks provided by the retained set and the identical by descent allele sharing in affected sib-pairs was assessed. After controlling for multiple testing, the set of SNPs rs2256774 and rs3118470, provides the best discrimination between the case and control genotype distributions (P-corrected=0.009). The relative risk between the least and most at-risk genotypes is 3.54 with a 95% confidence interval of [2.14-5.94]. Furthermore, the linkage information provided by the allele sharing between affected sibs is consistent with the retained set (P=0.80) but rejects the SNP reported in the literature (P=0.006). Establishing a valid modeling of a disease gene is essential to test its potential interaction with other genes and to reconstruct the pathophysiological pathways.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22085902      PMCID: PMC3283173          DOI: 10.1038/ejhg.2011.197

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  43 in total

1.  Polymorphisms in the IL2, IL2RA and IL2RB genes in multiple sclerosis risk.

Authors:  María L Cavanillas; Antonio Alcina; Concepción Núñez; Virginia de las Heras; Miguel Fernández-Arquero; Manuel Bartolomé; Emilio G de la Concha; Oscar Fernández; Rafael Arroyo; Fuencisla Matesanz; Elena Urcelay
Journal:  Eur J Hum Genet       Date:  2010-02-24       Impact factor: 4.246

2.  Genomewide study of multiple sclerosis.

Authors:  Sreeram V Ramagopalan; Carl Anderson; A Dessa Sadovnick; George C Ebers
Journal:  N Engl J Med       Date:  2007-11-22       Impact factor: 91.245

3.  New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility.

Authors:  Sophie Tezenas du Montcel; Laetitia Michou; Elisabeth Petit-Teixeira; José Osorio; Isabelle Lemaire; Sandra Lasbleiz; Céline Pierlot; Patrick Quillet; Thomas Bardin; Bernard Prum; François Cornelis; Françoise Clerget-Darpoux
Journal:  Arthritis Rheum       Date:  2005-04

4.  A new method to test genetic models in HLA associated diseases: the MASC method.

Authors:  F Clerget-Darpoux; M C Babron; B Prum; G M Lathrop; I Deschamps; J Hors
Journal:  Ann Hum Genet       Date:  1988-07       Impact factor: 1.670

5.  Genetic association between the interleukin-2 receptor-alpha gene and mode of onset of type 1 diabetes in the Japanese population.

Authors:  Eiji Kawasaki; Takuya Awata; Hiroshi Ikegami; Tetsuro Kobayashi; Taro Maruyama; Koji Nakanishi; Akira Shimada; Miho Uga; Susumu Kurihara; Yumiko Kawabata; Shoichiro Tanaka; Yasuhiko Kanazawa; Katsumi Eguchi
Journal:  J Clin Endocrinol Metab       Date:  2008-12-23       Impact factor: 5.958

6.  Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians.

Authors:  J P Rubio; J Stankovich; J Field; N Tubridy; M Marriott; C Chapman; M Bahlo; D Perera; L J Johnson; B D Tait; M D Varney; T P Speed; B V Taylor; S J Foote; H Butzkueven; T J Kilpatrick
Journal:  Genes Immun       Date:  2008-07-24       Impact factor: 2.676

7.  Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses.

Authors:  Lisa M Maier; David E Anderson; Christopher A Severson; Clare Baecher-Allan; Brian Healy; David V Liu; K Dane Wittrup; Philip L De Jager; David A Hafler
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

8.  IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility.

Authors:  Fuencisla Matesanz; Alfredo Caro-Maldonado; Maria Fedetz; Oscar Fernández; Roger L Milne; Miguel Guerrero; Concepción Delgado; Antonio Alcina
Journal:  J Neurol       Date:  2007-04-10       Impact factor: 4.849

9.  IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D).

Authors:  Antonio Alcina; María Fedetz; Dorothy Ndagire; Oscar Fernández; Laura Leyva; Miguel Guerrero; María M Abad-Grau; Carmen Arnal; Concepción Delgado; Miguel Lucas; Guillermo Izquierdo; Fuencisla Matesanz
Journal:  PLoS One       Date:  2009-01-06       Impact factor: 3.240

10.  Modeling the effect of PTPN22 in rheumatoid arthritis.

Authors:  Mathieu Bourgey; Hervé Perdry; Françoise Clerget-Darpoux
Journal:  BMC Proc       Date:  2007-12-18
View more
  5 in total

Review 1.  The genetics of multiple sclerosis: an up-to-date review.

Authors:  Pierre-Antoine Gourraud; Hanne F Harbo; Stephen L Hauser; Sergio E Baranzini
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

2.  Where is the causal variant? On the advantage of the family design over the case-control design in genetic association studies.

Authors:  Claire Dandine-Roulland; Hervé Perdry
Journal:  Eur J Hum Genet       Date:  2015-01-14       Impact factor: 4.246

3.  Mutation of Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma Related Genes and the Screening of Candidate Genes.

Authors:  Lizhuo Zhang; Lingyan Zhou; Qingqing Feng; Qinglin Li; Minghua Ge
Journal:  Front Oncol       Date:  2021-12-21       Impact factor: 6.244

Review 4.  The IL-2 - IL-2 receptor pathway: Key to understanding multiple sclerosis.

Authors:  Daphne Peerlings; Max Mimpen; Jan Damoiseaux
Journal:  J Transl Autoimmun       Date:  2021-09-21

5.  Feature selection based on differentially correlated gene pairs reveals the mechanism of IFN-β therapy for multiple sclerosis.

Authors:  Tao Jin; Chi Wang; Suyan Tian
Journal:  PeerJ       Date:  2020-03-16       Impact factor: 2.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.